TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Carls-Bergh Pharma AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 2,007 | 2,457 | 2,191 |
Financial expenses | 4 | 2 | 2 |
Earnings before taxes | 14 | 401 | 238 |
EBITDA | 53 | 434 | 268 |
Total assets | 2,244 | 2,215 | 1,014 |
Current assets | 1,205 | 1,104 | 895 |
Current liabilities | 387 | 320 | 309 |
Equity capital | 1,457 | 1,575 | 435 |
- share capital | 18 | 20 | 20 |
Employees (average) | 14 | 14 | 14 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 64.9% | 71.1% | 42.9% |
Turnover per employee | 143 | 176 | 156 |
Profit as a percentage of turnover | 0.7% | 16.3% | 10.9% |
Return on assets (ROA) | 0.8% | 18.2% | 23.7% |
Current ratio | 311.4% | 345.0% | 289.6% |
Return on equity (ROE) | 1.0% | 25.5% | 54.7% |
Change turnover | -251 | 307 | -195 |
Change turnover % | -11% | 14% | -8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.